89 studies found for:
Open Studies | "Mouth Neoplasms"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Oral Cancer Adjuvant Therapy (OCAT) Trial
|
||||
| 2 | Unknown † |
Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
|
||||
| 3 | Unknown † |
TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer
|
||||
| 4 | Recruiting |
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
|
||||
| 5 | Recruiting |
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
|
||||
| 6 | Recruiting |
Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL
|
||||
| 7 | Recruiting |
Oral Margin Spectroscopy Detection Using Optical Spectroscopy
|
||||
| 8 | Recruiting |
Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care
|
||||
| 9 | Recruiting |
Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers
|
||||
| 10 | Recruiting |
Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
|
||||
| 11 | Recruiting |
Vitamin D - Celecoxib Therapy
|
||||
| 12 | Recruiting |
GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer
|
||||
| 13 | Recruiting |
Polarized Reflectance Spectroscopy for Oral Lesions
|
||||
| 14 | Not yet recruiting |
Assessment of Mandibular Bone Invasion With MRI Using SWIFT
|
||||
| 15 | Unknown † |
The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
|
||||
| 16 | Unknown † |
Diagnosis of Oral Precancers and Cancers Using Optic Coherence Tomography
|
||||
| 17 | Recruiting |
Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
|
||||
| 18 | Unknown † |
Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
|
||||
| 19 | Recruiting |
Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
|
||||
| 20 | Unknown † |
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
|
† Indicates status has not been verified in more than two years
